BU-NOT-SET

CONTACT US
Tackling antimicrobial resistance
  • Drug product
Small bottles with antibiotics
Case study
A new centre for continuous mRNA manufacturing
  • Biologics
mRNA manufacture
Insight
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Fact sheet
  • Drug product
  • Manufacturing
Scalable solutions for high potent manufacturing
Insight
  • Drug product
  • Manufacturing
The stabilising power of lyophilisation in next-generation therapeutics
Insight
  • Drug product
  • Manufacturing
Unlocking the power of advanced sterile packaging
Fact sheet
  • Biologics
  • Manufacturing
Advancing continuous bioprocessing with Recimagine™
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation
Case study
  • Drug product
  • Manufacturing
Overcoming fixed-dose combination challenges for ALS
Video
  • Industry trends
What’s shaping the future of pharma?